Evidence map›Paper›PMID 33504762›Full record

ArticleNature communications2021

IDH1 mutations induce organelle defects via dysregulated phospholipids.

Adrian Lita, Artem Pliss, Andrey Kuzmin, Tomohiro Yamasaki, Lumin Zhang, Tyrone Dowdy, Christina Burks, Natalia de Val, Orieta Celiku, Victor Ruiz-Rodado and 10 more

Open access · goldAbstract read
In one paragraph

Article in Nature communications, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 49 papers.

0numbers the graph read from it
0cells of the map it votes in
49citing papers in PubMed
8.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

49 citing papers in PubMed, 74 citations in OpenAlex.

  1. Article
  2. Review
  3. Review
  4. Article
  5. bioRxiv : the preprint server for biology · 2026
    Article
  6. Review
  7. Article
  8. Review
  9. Review
  10. Article
  11. Article
  12. Review
  13. Article
  14. Preparation and Preclinical Evaluation ofMolecules (Basel, Switzerland) · 2024
    Article
  15. Review
  16. Article
  17. Article
  18. Article
  19. Review
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

20 authors at 5 institutions in 2 countries.

Adrian Lita *Neuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0003-0115-6077
Artem Pliss *Institute for Lasers, Photonics and Biophotonics, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
Andrey KuzminInstitute for Lasers, Photonics and Biophotonics, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
Tomohiro YamasakiNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-9858-9049
Lumin ZhangNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Tyrone DowdyNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-6833-8089
Christina BurksElectron Microscopy Laboratory, Frederick National Laboratory for Cancer Research, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.
Natalia de ValElectron Microscopy Laboratory, Frederick National Laboratory for Cancer Research, Center for Cancer Research, National Cancer Institute, Frederick, MD, 21702, USA.
Orieta CelikuNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.ORCID 0000-0002-0500-1032
Victor Ruiz-RodadoNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Elena-Raluca NicoliUndiagnosed Diseases Program, National Human Genome Research Institute (NHGRI), National Institutes of Health (NIH), Bethesda, MD, 20892, USA.
Michael KruhlakLaboratory of Cancer Biology and Genetics, National Cancer Institute, National Institutes of Health (NIH), Bethesda, MD, 20892, USA.
Thorkell AndressonProtein Characterization Laboratory of the Cancer Research Technology Program (CRTP), National Cancer Institute, Frederick, MD, 21702, USA.
Sudipto DasProtein Characterization Laboratory of the Cancer Research Technology Program (CRTP), National Cancer Institute, Frederick, MD, 21702, USA.
Chunzhang YangNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Rebecca SchmittInstitute for Lasers, Photonics and Biophotonics, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
Christel Herold-MendeDivision of Neurosurgical Research, Department of Neurosurgery, University Hospital Heidelberg, Heidelberg, Germany.
Mark R GilbertNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA.
Paras N PrasadInstitute for Lasers, Photonics and Biophotonics, University at Buffalo, State University of New York, Buffalo, NY, 14260, USA.
Mioara LarionNeuro-Oncology Branch, National Cancer Institute, Center for Cancer Research, National Institutes of Health, Bethesda, MD, USA. mioara.larion@nih.gov.ORCID 0000-0002-7016-9587
National Institutes of Health · USUniversity at Buffalo, State University of New York · USCancer Research Center · USFrederick National Laboratory for Cancer Research · USHeidelberg University · DE

Funding

CCR Microscopy CoreZICBC010858 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI KRUHLAK, MICHAEL · 2009 to 2025
$14.8M
Nrf2-goverened metabolic reprogram in IDH1-mutated gliomaZIABC011761 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI YANG, CHUN ZHANG · 2017 to 2025
$3.4M
Develop RAMAN imaging to visualize metabolism in cell lines and tissueZIABC011711 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARION, MIOARA · 2016 to 2025
$3.3M
Metabolite profiling of patients blood, urine, cerebrospinal fluid and tissueZIABC011709 · NCI · DIVISION OF BASIC SCIENCES - NCI · PI LARION, MIOARA · 2016 to 2025
$1.6M
Novel single cell assay for quantitative analysis of cell heterogeneity by noninvasive probing of molecular composition of specific organelles in individual cellsR44GM116193 · NIGMS · ADVANCED CYTOMETRY INSTRUMENTATION SYS · PI KUZMIN, ANDREY · 2017 to 2018
$1.2M
NIGMS NIH HHS R44 GM116193
6 · The paper itself

Abstract

Infiltrating gliomas are devastating and incurable tumors. Amongst all gliomas, those harboring a mutation in isocitrate dehydrogenase 1 mutation (IDH1

Indexed as

Cell Line, TumorEndoplasmic ReticulumGlioblastomaGolgi ApparatusHumansIsocitrate DehydrogenaseModels, BiologicalMutationOligodendrogliomaOrganellesPhospholipidsStearoyl-CoA DesaturaseIDH1 protein, humanIsocitrate DehydrogenasePhospholipidsSCD1 protein, humanStearoyl-CoA Desaturase

Identifiers

PMID33504762
PMCPMC7840755
OpenAlexW3123719885

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.